Israel vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Israel
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Israel rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Israel
- Kazakhstan
How they compare
Israel currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2006 it was Kazakhstan ahead.
Israel ranks 1st and Kazakhstan ranks 1st of 180 countries.
Across the 3 decades both report, Israel averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Israel | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.8% | 50.2% | 14.5% | Israel |
| 2010s | 59.6% | 86.9% | 27.3% | Kazakhstan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Israel or Kazakhstan?
- Israel, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Israel and Kazakhstan?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Kazakhstan?
- 18 years are reported by both, from 2006 to 2024.
- How do Israel and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Israel ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.